Saham Gilead: Beli Distorsi Sebelum Laporan Q2 Menjelaskannya (NASDAQ:GILD)
· seekingalpha.com
Waralaba HIV Gilead Sciences tumbuh 8% dengan perlindungan paten hingga 2036 dan hingga tujuh peluncuran baru pada 2033. Baca mengapa saham GILD layak beli.
There is a specific kind of number that is making a perfectly healthy business look like it is in shambles, and Gilead Sciences ( GILD ) is about to be one of t...